Defining the molecular basis of Arf and Hdm2 interactions

Journal of Molecular Biology

Volumn 314, Issue 2, 2001, Pages 263-277

  Bothner, Brian ^a,b   Lewis, William S ^a   DiGiammarino, Enrico L ^a   Weber, Jason D ^a   Bothner, Sarah J ^a   Kriwacki, Richard W ^a,b  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

Dynamic disorder; Nucleolar localization; p53; Supramolecular assemblies; Ubiquitination

Indexed keywords

ARF PROTEIN; PROTEIN MDM2; PROTEIN P53; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; BINDING KINETICS; CANCER RESEARCH; CIRCULAR DICHROISM; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; REGULATORY MECHANISM; SURFACE PLASMON RESONANCE;

EID: 0035941033     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmbi.2001.5110     Document Type: Article

References (63)

1. The Pezcoller lecture: Cancer cell cycles revisited
2. Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest
3. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4
4. Tumor surveillance via the ARF-p53 pathway
5. Role of the INK4a locus in tumor suppression and cell mortality
6. Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF
7. The p16INK4A/CDKN2A tumor suppressor and its relatives
8. Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization
9. E1A signaling to p53 involves the p19(ARF) tumor suppressor
10. p14ARF links the tumour suppressors RB and p53
11. p19ARF links the tumour suppressor p53 to Ras
12. p19(Arf) induces p53-dependent apoptosis during, abelson virus-mediated pre-B cell transformation
13. The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2's inhibition of p53
14. Functional and physical interactions of the ARF tumor suppressor with p53 and Mdm2
15. The alternative product from the human CDKN2A locus, p14(ARF), participates in a regulatory feedback loop with p53 and MDM2
16. ARF promotes MDM2 degradation and stabilizes p53: Arf-INK4A locus deletion impairs both the Rb and p53 tumor suppressor pathways
17. The p53-mdm-2 autoregulatory feedback loop
18. mdm2 expression is induced by wild-type p53 activity
19. Structure of the MDM2 oncoprotein bound to the p53 tumor suppressor transactivation domain
20. Oncoprotein Mdm2 conceals the activation domain of tumor suppressor p53
21. The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation
22. Nucleo-cytoplasmic shuttling of the hdm2 oncoprotein regulates the levels of the p53 protein via a pathway used by the human immunodeficiency virus rev protein
23. Nuclear export is required for degradation of endogenous p53 by MDM2 and human papillomavirus E6
24. Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53
25. Association of p19(ARF) with Mdm2 inhibits ubiquitin ligase activity of Mdm2 for tumor suppressor p53
26. Mdm2 is a RING finger-dependent ubiquitin protein ligase for itself and p53
27. P19(ARF) stabilizes p53 by blocking nucleo-cytoplasmic shuttling of Mdm2
28. An N-terminal p14ARF peptide blocks Mdm2-dependent ubiquitination in vitro and can activate p53 in vivo
29. Stabilization of p53 by p14ARF without relocation of MDM2 to the nucleolus
30. Nucleolar Arf sequesters Mdm2 and activates p53
31. Identification of a cryptic nucleolar-localization signal in MDM2
32. Cooperative signals governing ARF-mdm2 interaction and nucleolar localization of the complex
33. Solution structure of the p53 regulatory domain of the p19Arf tumor suppressor protein
34. Mutations in human ARF exon 2 disrupt its nucleolar localization and impair its ability to block nuclear export of MDM2 and p53
35. p300/Mdm2 complexes participate in Mdm2-mediated p53 degradation
36. Stimulation of E2F1/DP1 transcriptional activity by MDM2 oncoprotein
37. Physical and functional interactions between p53 and cell cycle co-operating transcription factors, E2F1 and DP1
38. Interaction between the retinoblastoma protein and the oncoprotein MDM2
39. The ribosomal L5 protein is associated with mdm-2 and mdm-2-p53 complexes
40. MDM2 expression during mouse embryogenesis and the requirement of p53
41. The p53-associated protein MDM2 contains a newly characterized zinc-binding domain called the RING finger
42. The MDM2 oncoprotein binds specifically to RNA through its RING finger domain
43. Metal and RNA binding properties of the hdm2 RING finger domain
44. Sequence-dependent correction of random coil NMR chemical shifts
45. Structural studies of p21(waf1/cip1/sdi1) in the free and Cdk2-bound state: Conformational disorder mediates binding diversity
46. Application of multiple sequence alignment profiles to improve protein secondary structure prediction
47. Equilibrium NMR studies of unfolded and partially folded proteins
48. The importance of being unfolded
49. Intrinsically unstructured proteins: Re-assessing the protein structure-function paradigm
50. Probing protein/protein interactions with mass spectrometry and isotopic labeling: Analysis of the p21/Cdk2 complex
51. Coupling of local folding to site-specific binding of proteins to DNA
52. Autoinhibition and activation mechanisms of the Wiskott-Aldrich syndrome protein
53. The Flory isolated-pair hypothesis is not valid for polypeptide chains: Implications for protein folding
54. The nucleolus: An old factory with unexpected capabilities
55. The MDM2 RING-finger domain is required to promote p53 nuclear export
56. Activity of MDM2, a ubiquitin ligase, toward p53 or itself is dependent on the RING finger domain of the ligase
57. The contribution of the RING finger domain of MDM2 to cell cycle progression
58. An intact HDM2 RING-finger domain is required for nuclear exclusion of p53
59. Structure of a c-Cb1-UbcH7 complex: RING domain function in ubiquitin-protein ligases
60. Sensitivity enhanced detection of weak nuclei using heteronuclear multiple quantum coherence
61. Natural abundance nitrogen-15 NMR by enhanced heteronuclear spectroscopy
62. Backbone dynamics of a free and a phosphopeptide-complexed Src homology 2 domain studied by 15N NMR relaxation